NYSE · Healthcare · Medical Instruments & Supplies · Italy
Stevanato Group Spa is a mid cap company (market value between $2 billion and $10 billion) in the Medical Instruments & Supplies industry.
Intrinsic value, DCF valuation, financial health and value investing analysis for the Stevanato Group Spa stock.
Fairly valued: intrinsic value $15.24 per share, market price $15.25, margin of safety -0.0% (as of 2026-11-17).
Discounting its cash flows at 9.0% (average of 2 methods) values the shares at $15.24; the price of $15.25 sits right on that value.
6 more funds hold it; the full list is part of the paid plan.
All 52 Medical Instruments & Supplies stocks
STVN is fairly valued (as of the 2026-11-17 close). Discounting its cash flows at 9.0% (average of 2 methods) values the shares at $15.24; the price of $15.25 sits right on that value.
$15.24 per share (as of the 2026-11-17 close), against a market price of $15.25. That is a margin of safety of -0.0%. The value is the average of the 2 valuation methods that apply to this company, recomputed every night after the US close.